Common Stock, Shares, Outstanding of Janux Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Janux Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Janux Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 60,384,283, a 2.2% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Janux Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 60,384,283 +1,319,677 +2.2% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 60,123,602 +7,786,363 +15% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 59,297,814 +7,135,599 +14% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 59,168,490 +7,327,919 +14% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 59,064,606 +12,812,166 +28% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 52,337,239 +6,185,812 +13% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 52,162,215 +10,294,679 +25% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 51,840,571 +10,037,764 +24% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 46,252,440 +4,636,180 +11% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 46,151,427 +4,600,723 +11% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 41,867,536 +366,267 +0.88% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 41,802,807 +409,147 +0.99% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 41,616,260 +373,123 +0.9% 31 Dec 2022 10-K 08 Mar 2024 2023 FY
Q3 2022 41,550,704 +378,741 +0.92% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 41,501,269 +406,710 +0.99% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 41,393,660 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 41,243,137 +40,196,538 +3841% 31 Dec 2021 10-K 10 Mar 2023 2022 FY
Q3 2021 41,171,963 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 41,094,559 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q4 2020 1,046,599 31 Dec 2020 10-K 18 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.